Home / Discover / Fund

quant Business Cycle Fund

quant Mutual Fund Sectoral / Thematic As of 2026-07-31
Exposure data needs interpretation. Reported asset buckets total 128%, so they are not additive portfolio weights. This can occur when derivatives, collateral or disclosure classifications overlap. Position weights remain shown as reported.
Holdings
30
Concentrated
Top 10 weight
90%
Concentration
Strategy data
N/A
Not reported
Equity
72%
Asset allocation

Portfolio

11Sectors 8Large positions 10.9%Top: Pharmaceuticals & Biotechnology 21.4%Cash

Market-cap allocation

Large cap25%
Mid cap37%
Small cap10%

Reported exposures

These percentages may overlap and should not be added together.

Equity72%
Debt7%
Cash21%
Other27%

Top holdings

Divi's Laboratories Limited 25/08/2026Pharmaceuticals & Biotechnology
6.5%

AI Smart summary

Portfolio read

  • 72% equity, 7% debt, 21% cash.
  • 30 disclosed positions across 11 classified equity sectors.
  • Largest equity sector is Pharmaceuticals & Biotechnology at 10.9% of the portfolio.

Watchpoints

  • Top 10 positions account for 90%, indicating high portfolio concentration.
  • Reported asset exposures do not reconcile to 100%; derivative, collateral or source-classification effects may be present.
  • Cash and cash equivalents are 21%, which can create performance drag when markets rise.

Auto-generated from fund metrics. Educational only - not investment advice.

Peer comparison

Other funds in Sectoral / Thematic.

HDFC Manufacturing fund91 holdings · 34% top 10 · 80% AS
UTI Quant Fund89 holdings · 36% top 10
Icici Prudential Energy Opportunities Fund88 holdings · 43% top 10 · 83% AS
ICICI Prudential Business Cycle Fund86 holdings · 50% top 10 · 70% AS
Edelweiss Technology Fund84 holdings · 54% top 10
Axis Business Cycles Fund81 holdings · 29% top 10 · 67% AS

Sector exposure

Full industry / sector breakdown aggregated from the fund's holdings.

Power9.2%